Quick filters
- Cytori Reports First Quarter 2013 Business and Financial Results Business Wire | Thursday May 9, 2013 4:01PM
- Cytori to Webcast First Quarter Financial Results on May 9 Business Wire | Thursday May 2, 2013 8:00AM
- Cytori to Webcast at the Future Leaders in the Biotech Industry Conference on April 5, 2013 Business Wire | Friday March 29, 2013 8:00AM
- Cytori Patents Method of Treating Renal Diseases Using Adipose-Derived Regenerative Cells Business Wire | Thursday March 28, 2013 8:00AM
- Cytori Provides Update in 510(k) Appeal Decision Business Wire | Friday March 22, 2013 2:24PM
- Cytori Therapeutics To Present at the 25th Annual Roth Conference on March 18 Business Wire | Monday March 11, 2013 8:00AM
- Cytori Reports 2012 Business and Financial Results; Provides Outlook for 2013 Business Wire | Thursday March 7, 2013 4:05PM
- Cytori to Webcast Fourth Quarter and Year End Financial Results on March 7 Business Wire | Thursday February 28, 2013 8:00AM
- Cytori Appoints Dr. Steven Kesten as Executive Vice President and Chief Medical Officer Business Wire | Tuesday February 26, 2013 8:00AM
- Intravase® Approval Opens Vascular Market for Cytori Business Wire | Monday February 25, 2013 9:25AM
- Cytori Announces Presentation at Biotech Showcase™ on January 8th Business Wire | Friday January 4, 2013 8:00AM
- Cytori Therapeutics Prices $20.0 Million Public Offering of Common Stock Business Wire | Friday December 14, 2012 9:19AM
- Cytori Therapeutics Proposes Public Offering of Common Stock Business Wire | Thursday December 13, 2012 4:01PM
- Cryptoglandular Fistula Repair Case Series Using Cytori Cell Therapy Published in the British Medical Journal: Case Reports Business Wire | Monday November 12, 2012 7:30AM
- Cytori Provides Business Update and Reports Third Quarter and Nine Month 2012 Results Business Wire | Thursday November 8, 2012 4:05PM
- Cytori to Webcast Third Quarter Financial Results on November 8 Business Wire | Thursday November 1, 2012 7:30AM
- Cytori Therapeutics Announces Company Presentation the 2012 Stem Cell Meeting on the Mesa's Investor and Partnering Forum on October 30 Business Wire | Friday October 26, 2012 8:00AM
- Cardiovascular and Chronic Liver Disease Cell Therapy Clinical Studies Approved in Japan Business Wire | Thursday October 25, 2012 7:30AM
- Investigator-Sponsored Cell Therapy Clinical Study for Scleroderma Initiated in France Business Wire | Tuesday October 23, 2012 7:37AM
- First Patient Treated in Cytori's U.S. Cell Therapy Heart Failure Trial Business Wire | Thursday October 11, 2012 8:00AM
Live Discussion of CYTX on StockTwits